Deutsche Pfandbriefbank AG 22.12.2015 11:23 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification of Major Holdings 1. Details of issuer Deutsche Pfandbriefbank AG Freisinger Strasse 5 85716 Unterschleissheim Germany 2. Reason for notification X Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments Change of breakdown of voting rights Other reason: 3. Details of person subject to the notification obligation Name: City and country of registered office: Morgan Stanley Wilmington, Delaware United States of America (USA) 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. Morgan Stanley & Co. International plc 5. Date on which threshold was crossed or reached 15.12.2015 6. Total positions % of voting % of voting rights total of total number rights attached through instruments both in % of voting to shares (total (total of 7.b.1 + (7.a. + rights of of 7.a.) 7.b.2) 7.b.) issuer Result- 7,44 % 3,05 % 10,48 % 134475308 ing situat- ion Previo- 4,43 % 6,04 % 10,47 % / us notifi- cation 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in % direct (Sec. indirect (Sec. direct (Sec. indirect 21 WpHG) 22 WpHG) 21 WpHG) (Sec. 22 WpHG) DE0008019001 0 10001456 0 % 7,44 % Total 10001456 7,44 % b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG Type of instrument Expirati- Exercise Voting Votin- on or or rights g maturity conversio- absolut- right- date n period e s in % Right of recall over securities at any at any 4097705 3,05 lending agreements / time / time / % Rueckuebertragungsansprueche aus jederzei- jederzeit einem Wertpapierdarlehen t Total 4097705 3,05 % b.2. Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG Type of Expiration Exercise or Cash or Voting Voting instrume- or maturity conversion physical rights rights nt date period settlement absolute in % % Total % 8. Information in relation to the person subject to the notification obligation Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting % of voting rights Total of both rights (if at through instruments (if (if at least least held 3% or at least held 5% or held 5% or more) more) more) Morgan Stanley % % % Morgan Stanley % % % Capital Management, LLC Morgan Stanley % % % Domestic Holdings, Inc. Morgan Stanley % % % & Co. LLC --- --- --- --- Morgan Stanley % % % MSDW Offshore % % % Equity Services Inc. Fundlogic SAS % % % --- --- --- --- Morgan Stanley % % % Morgan Stanley % % % International Holdings Inc. Morgan Stanley % % % International Limited Morgan Stanley % % % UK Group Morgan Stanley % % % Investments (UK) Morgan Stanley 4,90 % % 7,94 % & Co. International plc 9. In case of proxy voting according to § 22 Abs. 3 WpHG Date of general meeting: Holding position after general meeting: % (equals voting rights) 22.12.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Deutsche Pfandbriefbank AG Freisinger Strasse 5 85716 Unterschleissheim Germany Internet: http://www.pfandbriefbank.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: Deutsche Pfandbriefbank AG: Release according to
Top 10 Most Recent News Articles
Gildan Activewear Faces Class Action over Alleged Fraud
A Battle Over the Truth: Gildan's Legal Troubles Alright, buckle up, folks—it's time to dig deep into the gritty side of investing, where the glossy annual reports meet cold, hard skepticism. Gildan Activewear Inc., or GIL on the NYSE if you're still keeping track, has managed to embroil itself in some legal stews that even a seasoned trader like me can't ignore. Let's...
Continue Reading
Labcorp Scoops Up BioReference Health For $722M+
Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...
Continue Reading
HYPOTHESIS Blends Style and Function in Health Gear
Pushing the Limits with HYPERX Knit Look, healthcare workers ain't just clocking in and out—they're on their feet all day, twisting, reaching, and moving. So when HYPOTHESIS tossed this shin-dig in Los Angeles for their HYPERX knit collection, it wasn't just to show off some snazzy scrubs. It was about bridging a gap: wellness meets grind. You reckon a pair of old...
Continue Reading
Brewer Foundation Shatters Records with IPPF Entries
A New Milestone in Global Debate The Brewer Foundation is making waves across the debate world, claiming a groundbreaking enrollment for their 2026-27 International Public Policy Forum (IPPF). Let’s talk numbers for a moment—506 teams from a whopping 62 different countries, not to mention new entries from places like France, Mexico, Curaçao, and Russia, all eager to...
Continue Reading
EQT's Bold Move: Qiagen Takeover Offer
Strategic Moves in Biotech: The EQT-Qiagen Deal EQT Private Equity's latest maneuver has seasoned investors raising an eyebrow. They've just put an all-cash public takeover offer on the table for Qiagen, and no, this isn't your run-of-the-mill acquisition—it's a play steeped in strategy and capital dynamics. EQT's Portfolio Puzzle: Where Does Qiagen Fit? Let's break it...
Continue Reading
Pearson Targets 2026 Growth with Strategic Moves
Pearson's Q3 Performance: Crunch Time Checking the rearview mirror at Pearson's nine-month journey into 2026, it's quite the sight. Q3 revved up with a 6% growth spurt, aligning neatly with market expectations. Ain't that a relief in today's rocky terrain of education and assessment? Holding a tight rein, they're on course to meet the mid-single digit revenue growth they...
Continue Reading
Essity's Q3 2026: Profits Hold Firm Amid Challenges
Essity's Balance Act in Q3: A Close Examination No looking through rose-tinted glasses here—Essity navigated the third quarter of 2026 with mixed indicators. Despite the broad strokes of stability, there's plenty beneath the surface worth a seasoned investor's eye. The company's net sales inched up by 4.1% to SEK 36,060 million. A nice figure, sure, but if you peek...
Continue Reading
Ben Felton to Lead AEIC as President for 2027
A New Face at the Helm of AEIC If you’ve been keeping tabs on the utility sector, then the recent shuffling of chairs over at the Association of Edison Illuminating Companies (AEIC) might have caught your eye. They just wrapped up their 142nd Annual Meeting in Ojai, where Ben Felton from Portland General Electric stepped into the limelight as the incoming President for...
Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ
Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...
Continue Reading
Annual Flu Shots May Save Lives: Accordia Health's Call
Flu Season Isn't Just Sniffles: Accordia Health Speaks Up Listen up folks, it’s that time again and no, it ain’t just about digging out last year's scarf. Flu season is rolling in faster than a train outta hell, and already folks are talking about flu cases creeping up during the summer sunshine. We got Dr. Cameron Kilpatrick over at Accordia Health ringing the bell...
Continue ReadingTop 5 Most Recently Viewed Articles
Celmatix Unveils Innovative JNK Inhibitor for Women's Health
Celmatix Therapeutics Announces New Drug Program Celmatix Therapeutics, a biotechnology company dedicated to women's health, has recently launched an ambitious drug program focusing on a novel Jun-N-terminal kinase (JNK) inhibitor. This innovative therapeutic drug candidate is designed to effectively target pain and inflammation associated with various female health...
Continue Reading
Accelera's 100 MW Electrolyzer Powers Green Hydrogen Vision
Accelera's Role in Green Hydrogen Production Accelera by Cummins, recognized for its commitment to zero-emissions solutions, is set to revolutionize the green hydrogen landscape with a groundbreaking 100-megawatt (MW) proton exchange membrane (PEM) electrolyzer system. This development, aimed at enhancing renewable energy projects, will play an instrumental role in bp's...
Continue Reading
Curinos Amplero Achieves Gold Recognition at MarCom Awards
Curinos Amplero's Award-Winning AI Solution Recently, Curinos, a leading data intelligence firm in the financial sector, achieved prestigious recognition at the MarCom Awards for its innovative AI-powered platform, Amplero Personalization Optimizer. This platform, celebrated for its generative AI capabilities, played a vital role in the Private Wealth Cross-Sell Campaign...
Continue Reading
Florida Housing Market Trends: Sales Surge in 2025
Florida Housing Market Trends Overview As we dive into the current state of Florida's housing market, it's clear that exciting developments are taking place. In September, the sales of existing single-family homes experienced a robust increase of 13.6% compared to the previous year. Similarly, the sales of existing condo-townhouse units rose by 8% within the same...
Continue Reading
Oakio Achieves Excellence at Batimat 2024 Showcase
Oakio Concludes Successful Participation at Batimat 2024 Oakio has successfully concluded its participation in Batimat 2024, a notable event held recently. This exhibition provided an excellent platform for showcasing a wide array of innovative Wood-Plastic Composite (WPC) solutions while connecting with industry professionals from around the world. Highlighting...
Continue Reading